Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of Pt and Pt Radionuclides in Auger Electron Therapy

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2021 Apr 30

PMID 33916671

Citations 12

Authors

Kamil Wawrowicz

Agnieszka Majkowska-Pilip

Damian Gawel

Ewelina Chajduk

Tadeusz Pienkowski

Aleksander Bilewicz

Affiliations

Soon will be listed here.

Abstract

Pt and Pt radionuclides are therapeutically attractive Auger electron emitters with notably high Auger electron yield per decay. The present paper summarizes the first step of research on the applications of core-shell (Au@Pt) nanoparticles for electron Auger therapy of HER2+ (human epidermal growth factor receptor 2) breast cancer and hepatocellular carcinoma. Gold nanoparticles (30 nm) were synthesized covered with a platinum shell at high efficiency (>80%) and were further evaluated for in vitro studies such as binding affinity, internalization and cytotoxicity. To find the mechanism(s) responsible for platinum cytotoxicity in HepG2 cells, the platinum concentration in isolated cell nuclei and cytoplasm was determined using ICP-MS (inductively coupled plasma mass spectrometry). Lack of platinum in cell nuclei suggests that the cytotoxic effect is associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Studies carried out on the SKOV-3 cell line with the use of a synthesized targeting bioconjugate (Au@Pt-PEG-trastuzumab) revealed a high affinity of this preparation to HER2+ cells, its internalization, its placement in the perinuclear area and partial intranuclear location. The specific binding for HER2 negative cells, MDA-MB-231, was negligible and Au@Pt-PEG-trastuzumab did not enter these cells. The results obtained are promising and warrant future investigation of Auger electron therapy using Pt and Pt based radiopharmaceuticals.

Citing Articles

Pt-Au Nanoparticles in Combination with Near-Infrared-Based Hyperthermia Increase the Temperature and Impact on the Viability and Immune Phenotype of Human Hepatocellular Carcinoma Cells.

Szwed M, Jost T, Majka E, Gharibkandi N, Majkowska-Pilip A, Frey B Int J Mol Sci. 2025; 26(4).

PMID: 40004038 PMC: 11855494. DOI: 10.3390/ijms26041574.

Au@Pd Core-Shell Nanoparticles Conjugated to Panitumumab for the Combined β-Auger Electron Therapy of Triple-Negative Breast Cancer.

Gharibkandi N, Majkowska-Pilip A, Walczak R, Wierzbicki M, Bilewicz A Int J Mol Sci. 2025; 25(24.

PMID: 39769315 PMC: 11676729. DOI: 10.3390/ijms252413555.

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): An Emerging Tool in Radiopharmaceutical Science.

Klika K, Han J, Busse M, Soloshonok V, Javahershenas R, Vanhaecke F J Am Chem Soc. 2024; 146(45):30717-30727.

PMID: 39478417 PMC: 11565647. DOI: 10.1021/jacs.4c12254.

Radiation nanomedicines for cancer treatment: a scientific journey and view of the landscape.

Reilly R, Georgiou C, Brown M, Cai Z EJNMMI Radiopharm Chem. 2024; 9(1):37.

PMID: 38703297 PMC: 11069497. DOI: 10.1186/s41181-024-00266-y.

Au@Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of Pd/Ag in vivo generator in combined β auger electron therapy.

Gharibkandi N, Wawrowicz K, Majkowska-Pilip A, Zelechowska-Matysiak K, Wierzbicki M, Bilewicz A EJNMMI Radiopharm Chem. 2023; 8(1):26.

PMID: 37821747 PMC: 10567614. DOI: 10.1186/s41181-023-00212-4.

References

Mironava T, Simon M, Rafailovich M, Rigas B . Platinum folate nanoparticles toxicity: cancer vs. normal cells. Toxicol In Vitro. 2013; 27(2):882-9. DOI: 10.1016/j.tiv.2013.01.005. View

Akhtar M, Ahamed M, Alhadlaq H, Kumar S, Alrokayan S . Mitochondrial dysfunction, autophagy stimulation and non-apoptotic cell death caused by nitric oxide-inducing Pt-coated Au nanoparticle in human lung carcinoma cells. Biochim Biophys Acta Gen Subj. 2019; 1864(1):129452. DOI: 10.1016/j.bbagen.2019.129452. View

Chanda N, Kattumuri V, Shukla R, Zambre A, Katti K, Upendran A . Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity. Proc Natl Acad Sci U S A. 2010; 107(19):8760-5. PMC: 2889350. DOI: 10.1073/pnas.1002143107. View

Jiang B, Zhang R, Zhang J, Hou Y, Chen X, Zhou M . GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy. Theranostics. 2019; 9(8):2167-2182. PMC: 6531302. DOI: 10.7150/thno.30867. View

Zhu Z, Tao F, Zheng F, Chang R, Li Y, Heinke L . Formation of nanometer-sized surface platinum oxide clusters on a stepped Pt(557) single crystal surface induced by oxygen: a high-pressure STM and ambient-pressure XPS study. Nano Lett. 2012; 12(3):1491-7. DOI: 10.1021/nl204242s. View

Li Y, Hu Y, Xiao J, Liu G, Li X, Zhao Y . Investigation of SP94 Peptide as a Specific Probe for Hepatocellular Carcinoma Imaging and Therapy. Sci Rep. 2016; 6:33511. PMC: 5030711. DOI: 10.1038/srep33511. View

Gaweda W, Pruszynski M, Cedrowska E, Rodak M, Majkowska-Pilip A, Gawel D . Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy. Nanomaterials (Basel). 2020; 10(10). PMC: 7589850. DOI: 10.3390/nano10102067. View

Ku A, Facca V, Cai Z, Reilly R . Auger electrons for cancer therapy - a review. EJNMMI Radiopharm Chem. 2019; 4(1):27. PMC: 6800417. DOI: 10.1186/s41181-019-0075-2. View

Cai Z, Yook S, Lu Y, Bergstrom D, Winnik M, Pignol J . Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with Lu. Pharm Res. 2016; 34(3):579-590. DOI: 10.1007/s11095-016-2082-2. View

10.

Jeyaraj M, Gurunathan S, Qasim M, Kang M, Kim J . A Comprehensive Review on the Synthesis, Characterization, and Biomedical Application of Platinum Nanoparticles. Nanomaterials (Basel). 2019; 9(12). PMC: 6956027. DOI: 10.3390/nano9121719. View

11.

Hamasaki T, Kashiwagi T, Imada T, Nakamichi N, Aramaki S, Toh K . Kinetic analysis of superoxide anion radical-scavenging and hydroxyl radical-scavenging activities of platinum nanoparticles. Langmuir. 2008; 24(14):7354-64. DOI: 10.1021/la704046f. View

12.

Aghevlian S, Boyle A, Reilly R . Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons. Adv Drug Deliv Rev. 2015; 109:102-118. DOI: 10.1016/j.addr.2015.12.003. View

13.

Gao J, Liang G, Zhang B, Kuang Y, Zhang X, Xu B . FePt@CoS(2) yolk-shell nanocrystals as a potent agent to kill HeLa cells. J Am Chem Soc. 2007; 129(5):1428-33. DOI: 10.1021/ja067785e. View

14.

Kassis A . The amazing world of auger electrons. Int J Radiat Biol. 2005; 80(11-12):789-803. DOI: 10.1080/09553000400017663. View

15.

Chithrani B, Ghazani A, Chan W . Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006; 6(4):662-8. DOI: 10.1021/nl052396o. View

16.

Howell R, Kassis A, Adelstein S, Rao D, WRIGHT H, Hamm R . Radiotoxicity of platinum-195m-labeled trans-platinum (II) in mammalian cells. Radiat Res. 1994; 140(1):55-62. PMC: 9319989. View

17.

Gao Z, Ye H, Tang D, Tao J, Habibi S, Minerick A . Platinum-Decorated Gold Nanoparticles with Dual Functionalities for Ultrasensitive Colorimetric in Vitro Diagnostics. Nano Lett. 2017; 17(9):5572-5579. DOI: 10.1021/acs.nanolett.7b02385. View

18.

Dziawer L, Majkowska-Pilip A, Gawel D, Godlewska M, Pruszynski M, Jastrzebski J . Trastuzumab-Modified Gold Nanoparticles Labeled with At as a Prospective Tool for Local Treatment of HER2-Positive Breast Cancer. Nanomaterials (Basel). 2019; 9(4). PMC: 6523862. DOI: 10.3390/nano9040632. View

19.

Salvanou E, Stellas D, Tsoukalas C, Mavroidi B, Paravatou-Petsotas M, Kalogeropoulos N . A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225. Pharmaceutics. 2020; 12(2). PMC: 7076693. DOI: 10.3390/pharmaceutics12020188. View

20.

Cai Z, Chattopadhyay N, Yang K, Kwon Y, Yook S, Pignol J . In-labeled trastuzumab-modified gold nanoparticles are cytotoxic in vitro to HER2-positive breast cancer cells and arrest tumor growth in vivo in athymic mice after intratumoral injection. Nucl Med Biol. 2016; 43(12):818-826. DOI: 10.1016/j.nucmedbio.2016.08.009. View